ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "biomarkers and remission"

  • Abstract Number: 1416 • 2019 ACR/ARP Annual Meeting

    B Cell Profile for Early Identification of Optimal Responders to TNF-inhibitors in Rheumatoid Arthritis

    Cristina Sobrino1, Borja Hernández-Breijo 2, Carlota García-Hoz 3, Israel Nieto-Gañán 4, Victoria Navarro-Compán 5, Ana Martínez-Feito 6, javier Bachiller 1, Gema Bonilla 7, Cristina Pijoán-Moratalla 1, Paloma Lapuente-Suanzes 8, Dora Pascual-Salcedo 2, Alejandro Balsa 7, Garbiñe Roy 4, Mónica Vázquez Díaz 1, Luisa María Villar 4, Chamaida Plasencia 7 and Eulalia Rodríguez-Martín 4, 1Rheumatology Department, Ramón y Cajal University Hospital & IRYCIS, Madrid, Spain, 2Immuno-Rheumatology Research Group, IdiPAZ. La Paz University Hospital, Madrid, Spain, 3Immunology Department, Ramón y Cajal University Hospital & IRYCIS, Madrid, 4Immunology Department, Ramón y Cajal University Hospital & IRYCIS, Madrid, Spain, 5University Hospital La Paz, IdiPaz, Madrid, Spain, 6Immuno-Rheumatology Research Group, IdiPAZ & Immunology Department. La Paz University Hospital, MADRID, Spain, 7Immuno-Rheumatology Research Group, IdiPaz & Rheumatology Department. La Paz University Hospital, Madrid, Spain, 8University Hospital Ramón y Cajal, Madrid

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory and heterogeneous autoimmune disorder of unknown etiology characterized by progressive joint damage. Although TNF inhibitors (TNFi) have…
  • Abstract Number: 1315 • 2013 ACR/ARHP Annual Meeting

    14-3-3η and Its Auto-Antibodies Predict Response To Anti-TNF Therapy

    Walter P. Maksymowych1 and Anthony Marotta2, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Augurex Life Sciences Corp, North Vancouver, BC, Canada

    Background/Purpose: Serum 14-3-3η is an RA diagnostic marker and higher levels are associated with joint damage and more severe disease. Mechanistically, 14-3-3η upregulates factors involved…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences